Syntheses with heterocyclic ?-enaminonitriles: An expeditious synthetic approach to polyfunctionally substituted 5-phenylsulfonylthiophenes and their fused derivatives
摘要:
Phenylsulfonylacetophenones 1 react with a mixture of elemental sulfur and malononitrile to yield the corresponding 2-amino-4-aryl-5-phenylsulfonylthiophene-3-carbonitriles 2. Compound 2a could be annelated to the corresponding thieno[2,3-d]pyrimidine and thieno[2,3-c]-pyrazole derivatives 3 and 5 upon reaction with nitrogen nucleophiles (cyanamide and hydroxylamine hydrochloride), respectively. The applicability and synthetic potency of 5 to develop a facile convenient route to the polyfunctionally substituted thieno[2',3':3,4]pyrazolo[1,5-a]pyrimidines 8, 14, 17, 20, and 21 is reported. Chemical and spectroscopic evidences for the structures of the new compounds are presented.
Syntheses with heterocyclic ?-enaminonitriles: An expeditious synthetic approach to polyfunctionally substituted 5-phenylsulfonylthiophenes and their fused derivatives
摘要:
Phenylsulfonylacetophenones 1 react with a mixture of elemental sulfur and malononitrile to yield the corresponding 2-amino-4-aryl-5-phenylsulfonylthiophene-3-carbonitriles 2. Compound 2a could be annelated to the corresponding thieno[2,3-d]pyrimidine and thieno[2,3-c]-pyrazole derivatives 3 and 5 upon reaction with nitrogen nucleophiles (cyanamide and hydroxylamine hydrochloride), respectively. The applicability and synthetic potency of 5 to develop a facile convenient route to the polyfunctionally substituted thieno[2',3':3,4]pyrazolo[1,5-a]pyrimidines 8, 14, 17, 20, and 21 is reported. Chemical and spectroscopic evidences for the structures of the new compounds are presented.
Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
申请人:Tonani Roberto
公开号:US20090233813A1
公开(公告)日:2009-09-17
Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.